Future Perspectives: Mass Spectrometry for Spatial Localisation of Anti-Angiogenic Oil Palm Compounds

Area of Science:

• Oncology
• Biochemistry
• Analytical Chemistry

Background:

• Angiogenesis is crucial in colorectal cancer (CRC) progression, but understanding how nutraceuticals interact with tumor microenvironments is limited.
• Palm oil mill effluent (POME) contains bioactives with potential anti-angiogenic properties, yet their spatial function in CRC is uncharacterized.
• Current bulk analyses restrict mechanistic insights into bioactive compound behavior within complex tumor architectures.

Purpose of the Study:

• To propose a hypothesis that the spatial localization of POME-derived bioactives in CRC tissues predicts their anti-angiogenic activity.
• To introduce mass spectrometry imaging (MSI) as a tool to bridge compound localization and angiogenic function.
• To outline a framework for investigating POME bioactives in CRC for precision nutraceutical oncology.

Main Methods:

• Utilizing mass spectrometry imaging (MSI) platforms (MALDI, DESI, SIMS) for label-free, spatial co-localization.
• Mapping POME-derived compounds within intact CRC tissues alongside angiogenic mediators (VEGF, HIF-1α, NF-κB).
• Developing a four-component roadmap: POME profiling, spatial mapping, co-localization analysis, and functional validation.

Main Results:

• MSI enables spatially resolved analysis of POME bioactives and angiogenic mediators in CRC.
• This approach transcends limitations of conventional bulk analyses for mechanistic understanding.
• Identifies candidate oil palm-derived bioactives for spatial investigation based on existing evidence quality.

Conclusions:

• A spatially informed framework using MSI can elucidate the anti-angiogenic potential of POME bioactives in CRC.
• This approach supports POME valorization within precision nutraceutical oncology.
• Offers a strategy for anti-angiogenic intervention in CRC while addressing palm oil waste.